| CerbB-2、P53、ER、PR在乳腺癌中的表达及其临床意义 |
| |
| 引用本文： | 杨海松,罗轲,毛大华,黄建军,张世泳. CerbB-2、P53、ER、PR在乳腺癌中的表达及其临床意义[J]. 贵州医药, 2006, 30(3): 199-201 |
| |
| 作者姓名： | 杨海松 罗轲 毛大华 黄建军 张世泳 |
| |
| 作者单位： | 贵阳医学院附属医院,550004;贵阳医学院附属医院,550004;贵阳医学院附属医院,550004;贵阳医学院附属医院,550004;贵阳医学院附属医院,550004 |
| |
| 摘 要： | 目的探讨CerbB-2、P53、ER和PR在乳腺癌的表达及其临床意义。方法采用免疫组化SP法对198例乳腺癌组织标本进行CerbB-2、P53、ER和PR检测。结果阳性表达率:CerbB-2 为37．37％(74／198),P53为28．79％(57／198),ER为44．95％(89／198),PR为49．49％(98／198); CerbB-2和P53阳性表达率与有无淋巴结转移、临床分期有关(P<0．01);CerbB-2、P53共同阳性表达与淋巴结转移有关(P<0．01)。结论联合检测乳腺癌CerbB-2、P53、ER和PR基因袁达对判断预后和指导内分泌治疗有实用价值。
|
| 关 键 词： | 乳房肿瘤 预后 癌基因蛋白质CerbB-2 癌基因蛋白质P53 淋巴结转移 |
| 文章编号： | 1000-744X（2006）03-0199-03 |
Clinical significance of CerbB-2, P53, ER and PR expression in breast cancer |
| |
| Yang Haisong , Luo Ke , Mao Dahua ,et al.. Clinical significance of CerbB-2, P53, ER and PR expression in breast cancer[J]. Guizhou Medical Journal, 2006, 30(3): 199-201 |
| |
| Authors: | Yang Haisong Luo Ke Mao Dahua et al. |
| |
| Affiliation: | Department of Mastopathy , the first affiliated hospital of Guiyang medical college, Guiyang 550004 |
| |
| Abstract: | Objective To study the clinical significance of CerbB-2, P53, ER and PR expression in breast carcinoma tissues. Methods Using Immunohistochemistry technique (S-P) to detect the expression of CerbB-2, P53, ER and PR in 198 cases of breast cancer. Results The positive expression rates of CerbB-2, P53, ER and PR were 33. 37%, 28. 79%, 44. 95%, 49. 49% respectively in breast cancer specimens; there existed correlation between the positive expression of CerbB-2 and P53 and lymphatic metastasis and clinical stages (P<0. 01); the conjunct positive expression of CerbB-2 and P53 had a relationship with lymphatic metastasis (P<0. 01). Conclusion Combine detecting gene expression of CerbB-2, P53 and ER and PR in breast cancer were of practical value in determining prognoses and en-docrinotherapy. |
| |
| Keywords: | Breast cancer Prognoses Oncogene proteins CerbB-2 P53 Lymphgland Transfer |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
